Cite
MLA Citation
Ivo Abraham et al.. “Trilaciclib and the economic value of multilineage myeloprotection from chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer treated with first-line chemotherapy.” Journal of medical economics, vol. 24, n.d., pp. 71–83. http://access.bl.uk/ark:/81055/vdc_100147214735.0x00001b